Licensed Practical Nurse in District Of Columbia Medicare Details, Address, Contact
308 Licensed Practical Nurse nurses found. Showing 21 - 40
 Aminata U Nabie, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6120 Kansas Ave., Nw, Washington, DC 20011 Phone: 202-829-1719 |
Cordelia Malai, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |
Oluremi Orisabiyi, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Avenue, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |
Joselene N Neng, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw Ste 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |
Lashon Lulendo, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Avenue, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |
Mariama Njai, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 New Jersey Ave Se Ste 845, Washington, DC 20003 Phone: 202-545-6980 |
Tyisha Maxwell, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Suite 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |
Yomi Rahman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6030 Kansas Ave Nw Suite 201, Washington, DC 20011 Phone: 202-545-5040 |
Joy Orusa, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1118 Galloway St Ne, Washington, DC 20011 Phone: 770-312-9071 |
Sharon Cummings, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw, Ste. 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |
Connie Laverne Moore, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 New Jersey Ave Se Ste 845, Washington, DC 20003 Phone: 202-545-6980 |
Jeneba Fatmata Jalloh, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 New Jersey Ave Se Ste 845, Washington, DC 20003 Phone: 202-545-6980 |
Mrs. Raynice Thompson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2101 Martin Luther King Jr Ave Se # 1220, Washington, DC 20020 Phone: 202-585-7687 Fax: 202-442-1199 |
Ivette De Leon, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1100 New Jersey Ave Se Ste 845, Washington, DC 20003 Phone: 202-545-6980 |
Ms. Amy Annette Scherer, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 5801 Army Pentagon, Washington, DC 20310 Phone: 703-692-2625 |
Debbie Cozier, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1818 New York Ave Ne, 228, Washington, DC 20002 Phone: 202-832-8340 |
Alecia Linda Williams, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 406 M St Ne, Washington, DC 20002 Phone: 301-980-6772 |
Ms. Kim Renee Blowe, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Washington, DC 20012 Phone: 202-545-6980 |
Agnes Sumana, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2512 24th St Ne, Washington, DC 20018 Phone: 202-832-8340 Fax: 202-832-8341 |
Sattia Sesay, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw Ste 323, Washington, DC 20012 Phone: 202-723-3060 |
News Archive
First Edition: April 7, 2014
Today's headlines include stories about the next round of health law challenges the Obama administration faces as well as the new Medicare Advantage rates scheduled to be announced today.
Phase 3 results of TARGET 1 and TARGET 2 clinical trials released
Salix Pharmaceuticals, Ltd. today announced the successful outcome of two Phase 3, randomized, double-blind, placebo-controlled, multicenter trials, TARGET 1 and TARGET 2, designed to evaluate the efficacy and safety of rifaximin 550 mg TID in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).
Kinetic Concepts 2010 third quarter total revenue increases 2% to $506.7 million
Kinetic Concepts, Inc. today reported third quarter 2010 total revenue of $506.7 million compared to $504.4 million in the third quarter of 2009 and up 2% from the second quarter of 2010.
RPCI receives FDA approval to enroll patients in phase II clinical trial using I-PDT approach
Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.
› Verified 4 days ago